PapersFlow Research Brief
Alkaline Phosphatase Research Studies
Research Guide
What is Alkaline Phosphatase Research Studies?
Alkaline Phosphatase Research Studies is a cluster of over 26,000 scientific papers examining the regulation of bone mineralization through the enzyme alkaline phosphatase, including its roles in hypophosphatasia, matrix vesicles, biomineralization, and related molecular mechanisms such as those involving PHOSPHO1 and osteopontin.
Alkaline Phosphatase Research Studies encompasses 26,127 works focused on bone mineralization regulation, with key topics including hypophosphatasia, matrix vesicles, osteoblasts, enzyme replacement therapy, and proteins like PHOSPHO1 and osteopontin. Owen et al. (1990) in "Progressive development of the rat osteoblast phenotype in vitro: Reciprocal relationships in expression of genes associated with osteoblast proliferation and differentiation during formation of the bone extracellular matrix" demonstrated reciprocal gene expression patterns linking osteoblast proliferation, differentiation, and bone matrix formation. Zaidi (2007) in "Skeletal remodeling in health and disease" addressed skeletal remodeling processes central to understanding alkaline phosphatase's physiological roles.
Topic Hierarchy
Research Sub-Topics
Alkaline phosphatase in bone mineralization
Studies elucidate alkaline phosphatase's role in hydrolyzing pyrophosphate inhibitors during matrix vesicle-mediated mineralization by osteoblasts. Biochemical assays quantify enzyme activity in mineralization models.
Hypophosphatasia molecular pathology
Researchers characterize ALPL gene mutations causing hypophosphatasia, correlating genotypes with clinical severities from perinatal to adult forms. Functional studies assess mutant enzyme trafficking and stability.
Enzyme replacement therapy for hypophosphatasia
Clinical trials evaluate asfotase alfa's efficacy in improving mineralization, survival, and motor function in hypophosphatasia patients. Pharmacokinetic and immunogenicity studies optimize dosing regimens.
Matrix vesicles in biomineralization
Investigations detail matrix vesicle composition, transport, and nucleation of hydroxyapatite crystals during endochondral ossification. Imaging and proteomics reveal regulatory proteins like PHOSPHO1.
PHOSPHO1 in skeletal mineralization
Research demonstrates PHOSPHO1's role in generating inorganic phosphate within matrix vesicles, acting parallel to alkaline phosphatase. Knockout models reveal combined deficiencies' impact on bone quality.
Why It Matters
Alkaline Phosphatase Research Studies impacts clinical management of bone disorders like hypophosphatasia and prostate cancer through phosphatase activity as biomarkers. Huggins and Hodges (2002) in "Studies on Prostatic Cancer: I. The Effect of Castration, of Estrogen and of Androgen Injection on Serum Phosphatases in Metastatic Carcinoma of the Prostate" showed that serum phosphatase levels provided objective indices of prostate carcinoma activity, with castration reducing elevated enzymes, influencing endocrine therapies still used today with over 3,200 citations. Poole et al. (2005) in "Sclerostin is a delayed secreted product of osteocytes that inhibits bone formation" identified sclerostin from osteocytes as an inhibitor of bone formation, linking alkaline phosphatase pathways to potential treatments for osteoporosis and skeletal diseases. These findings support enzyme replacement therapies and biomineralization strategies in endocrinology and metabolism.
Reading Guide
Where to Start
"Progressive development of the rat osteoblast phenotype in vitro: Reciprocal relationships in expression of genes associated with osteoblast proliferation and differentiation during formation of the bone extracellular matrix" by Owen et al. (1990) because it provides an accessible experimental model of osteoblast differentiation and gene expression tied to bone matrix formation involving alkaline phosphatase.
Key Papers Explained
Owen et al. (1990) established osteoblast phenotypic progression and gene reciprocity in bone matrix formation, building foundational context for Zaidi (2007)'s "Skeletal remodeling in health and disease," which examines broader skeletal dynamics. Poole et al. (2005) in "Sclerostin is a delayed secreted product of osteocytes that inhibits bone formation" extends this by linking osteocyte signals to bone inhibition, connecting to mineralization regulation. Huggins and Hodges (2002) applied phosphatase assays clinically in prostate cancer, paralleling Ames (1966)'s methodological base in "[10] Assay of inorganic phosphate, total phosphate and phosphatases."
Paper Timeline
Most-cited paper highlighted in red. Papers ordered chronologically.
Advanced Directions
Studies continue on hypophosphatasia treatments and PHOSPHO1 roles in biomineralization, as indicated by the cluster's focus areas. No recent preprints or news from the last 6-12 months available, pointing to steady rather than rapidly evolving frontiers in bone mineralization mechanisms.
Papers at a Glance
Frequently Asked Questions
What is the role of alkaline phosphatase in bone mineralization?
Alkaline phosphatase regulates bone mineralization by hydrolyzing inorganic phosphates and contributing to matrix vesicle function in osteoblasts. Owen et al. (1990) showed its expression reciprocally relates to genes for osteoblast proliferation and differentiation during bone extracellular matrix formation. This enzyme is central to hypophosphatasia pathology when deficient.
How is alkaline phosphatase used as a biomarker in prostate cancer?
Serum alkaline phosphatase levels serve as objective indices of metastatic prostate carcinoma activity. Huggins and Hodges (2002) found castration, estrogen, and androgen injections altered serum phosphatases, with reductions indicating treatment efficacy. This approach enabled serial monitoring of tumor response.
What molecular mechanisms control alkaline phosphatase isozyme conversion?
The iap gene in Escherichia coli encodes a protein responsible for alkaline phosphatase isozyme conversion. Ishino et al. (1987) sequenced the 1,664-nucleotide iap gene, predicting a 345-amino-acid product. This identifies the gene product regulating isozyme forms.
How does sclerostin relate to alkaline phosphatase in bone formation?
Sclerostin, secreted by osteocytes, inhibits bone formation and interacts with mineralization pathways involving alkaline phosphatase. Poole et al. (2005) reported human osteocytes secrete sclerostin as a delayed product modulating bone turnover. This connects to osteoblast regulation observed in related studies.
What assays measure alkaline phosphatase activity?
The assay for inorganic phosphate, total phosphate, and phosphatases quantifies alkaline phosphatase function. Ames (1966) in "[10] Assay of inorganic phosphate, total phosphate and phosphatases" provided a standard method cited over 3,300 times. It supports histochemical and biochemical analyses in mineralization research.
What is the current state of alkaline phosphatase research?
Research includes 26,127 papers on bone mineralization, hypophosphatasia, and biomineralization with no reported 5-year growth data. Top-cited works span prokaryotic genetics to human skeletal diseases. No recent preprints or news coverage from the last 12 months is available.
Open Research Questions
- ? How do matrix vesicles and PHOSPHO1 interact with alkaline phosphatase to initiate biomineralization in osteoblasts?
- ? What are the precise molecular defects in hypophosphatasia and their impacts on enzyme replacement therapy efficacy?
- ? How does osteopontin modulate alkaline phosphatase activity during skeletal remodeling in health and disease?
- ? What regulatory networks link alkaline phosphatase expression to sclerostin secretion in osteocytes?
- ? Can bacterial models of iap gene regulation inform eukaryotic alkaline phosphatase isozyme control in bone cells?
Recent Trends
The field maintains 26,127 papers with no specified 5-year growth rate.
Highly cited classics like Ames with 3,336 citations and Huggins and Hodges (2002) with 3,201 citations dominate, reflecting sustained relevance in assays and clinical biomarkers.
1966No recent preprints or news coverage reported in the last 12 months.
Research Alkaline Phosphatase Research Studies with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Alkaline Phosphatase Research Studies with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers